A lot of ink has flowed describing the tough times that big pharma companies are experiencing as each, lemming-like, tumbles off the patent cliff.
Author Archives: Peter Winter
The Times They Are A-Changin’
October 15, 2012 – 1:15 pm
Kudos to the folks at Biotechnology Industry Organization (BIO) for selecting the industry’s “hot button” issues for panel discussions at the annual BIO Investor Forum (BIF) just concluded in San Francisco. In years past it has been my experience that…
What Global Financial Crisis? Capital Markets Back Biotechs
October 3, 2012 – 11:19 am
It is that time of year again when we take the pulse of the industry at the close of the third quarter. Overall we find that it is performing well, more so for public biotechs than private ones. Despite the…
Biotech Fundraising Slows in 1H12, Tougher Times Ahead?
July 9, 2012 – 11:35 am
There is no doubt that 2011 was a hot financing year for biotech and it was always going to be a tough act to follow.
Join the Conversation